Compounding pharmacies were put under the microscope after a deadly multistate meningitis outbreak in 2012 stemmed from contaminated compounded medication.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
“After assessing the need for a more focused and specialized evaluation of facilities’ sterile compounding practices, the Joint Commission recognized it was important to design a program that would help organizations reduce risk and harm,” said Robert Campbell, PharmD, a surveyor with the Joint Commission’s Hospital Accreditation Program. “Organizations that successfully achieve this certification have demonstrated compliance with nationally accepted standards of practice for sterile medication compounding.”
Any compounding pharmacy operating in or shipping to states with regulations that require compliance with the United States Pharmacopeial Convention General Chapters 797 or 795 can earn the certification
Click here for more information.
More articles on patient safety:
Researchers failed to tell anemic patients their diagnosis in NIH trial
New lawsuit alleges mold killed 2 more patients at third UPMC hospital
6 hospitals warning patients of heater-cooler infection risks
